NCT00432263
Withdrawn
Phase 4
Placebo-Controlled Trial On The Efficacy Of Growth Hormone Replacement Therapy In Patients With Growth Hormone Deficiency After Traumatic Brain Injury
ConditionsBrain Injuries
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Brain Injuries
- Sponsor
- Pfizer
- Primary Endpoint
- The primary endpoint is the change from baseline in the CogState™ composite score at Week 36.
- Status
- Withdrawn
- Last Updated
- 11 years ago
Overview
Brief Summary
To establish the effects of genotropin replacement in patients with severe growth hormone deficiency after traumatic brain injury on cognitive function.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Have had a previous traumatic brain injury (more than 1 year and less than 5 years) prior to the screening visit.
- •Have an Extended Glasgow Outcome Scale (GOS-E) more than or equal to 5.
Exclusion Criteria
- •Active systemic malignancy or active intracranial tumor. A successfully treated tumor or malignancy is not an exclusion criterion if the patient has not had active disease for 5 years and is not currently receiving maintenance chemotherapy, (except for basal cell skin cancers.
- •Receiving treatment with prednisolone in doses above 10 mg/day or treatment with other oral glucocorticosteroids above replacement doses is not permitted throughout the study. Topical and inhaled corticosteroids are permitted.
Outcomes
Primary Outcomes
The primary endpoint is the change from baseline in the CogState™ composite score at Week 36.
Secondary Outcomes
- Change CogState™ at Week 12, 24, 60 and 72. Change in lean body mass and fat mass at Week 36 and 72. Change in the Extended Glasgow Outcome Scale at week 36 and 72. Change in quality of life at week 24, 36, 60 and 72. Summary of change in cardiovascular
Similar Trials
Terminated
Phase 4
Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain InjuryBrain InjuriesGrowth Hormone DeficiencyNCT00555009Pfizer10
Not yet recruiting
Early Phase 1
Growth Hormone Deficiency in Mild Traumatic Brain InjuryGrowth Hormone TreatmentGrowth Hormone DeficiencyConcussion, MildConcussion Post SyndromeNCT05660356University of Calgary20
Terminated
Phase 3
Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone DeficiencyGrowth Hormone DeficiencyNCT00630487Pfizer9
Completed
Phase 2
Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary TrialHeart FailureGrowth Hormone DeficiencyIschemic Heart DiseaseNCT00591760Federico II University56
Completed
Phase 2
Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.Traumatic Brain InjuryNCT00766038University of Pennsylvania63